The partners will develop panels to stratify patients with obesity and diabetes into surgical and alternate intervention groups in an upcoming clinical trial.
The study, funded last month by the NIH, will use SRM-MS to identify proteins from a subset of promising pathways that are associated with DKD patients' progression to end-stage disease.
The partners are using genomic data to improve understanding of cardiovascular disease and diabetes and identify markers linked to drug response.
The Biomarker Development Center will use Singulex's Single Molecule Counting technology to quantify ultra-low level biomarkers.
The financing is an extension of a Series E round completed in early 2014 and brings the total amount in the round to $20 million.
Genetic study of familial hypercholesterolemia implicates link between type 2 diabetes risk and cholesterol transport.
Using the Immunochip, University of Virginia researchers fine-mapped type 1 diabetes susceptibility loci and examined potential causal variants.
The agreement follows a pilot study, under which around 500 Aetna employees participated in Newtopia's personalized health program.
Researchers from the US and Finland characterized the gut microbiomes of infants at risk of developing type 1 diabetes to find changes associated with disease progression.
Researchers have identified obesity-related methylation shifts in mouse and human fat cells that overlap with regions in the genome implicated in type 2 diabetes.
The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.
60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.
In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.
A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.